Don't Wait to Diagnose AMD
Are your patients going undiagnosed?
Age-related macular degeneration (AMD) is the leading cause of adult blindness in developed countries. In fact, AMD is three times more prevalent than glaucoma. And the problem is only expected to grow as the population ages.
A 2017 study published in JAMA Ophthalmology estimates there are currently 14 million patients with AMD in the U.S. But even with regular exams using current imaging tools, an additional 25% are undiagnosed.1 What does that 25% mean to your practice?
The current standard is for us to wait around until we see macular degeneration progressing in someone’s eye. We now know we can identify it earlier, up to 3 years earlier before it ever shows up in their eye. I truly believe dark adaptation testing should be the standard of care.
Stages of AMD
As a progressive disease, AMD reveals itself in stages. Detecting AMD at the subclinical level offers patients the best chance to prevent blindness.
Symptoms & Risk Factors
Understanding the symptoms and risk factors will help identify AMD earlier.
AMD Testing Options
Is your practice making the best use of the available AMD testing methods?
Starting treatment of AMD early helps delay or prevent blindness.